Two Sigma Investments, LP Lantern Pharma Inc. Transaction History
Two Sigma Investments, LP
- $41.6 Billion
- Q4 2024
A detailed history of Two Sigma Investments, LP transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 16,545 shares of LTRN stock, worth $62,705. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,545
Previous 34,340
51.82%
Holding current value
$62,705
Previous $126,000
58.73%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding LTRN
# of Institutions
35Shares Held
2.48MCall Options Held
4.6KPut Options Held
600-
Bios Capital Management, LP Fort Worth, TX1.21MShares$4.58 Million4.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$1.38 Million0.0% of portfolio
-
Cm Management, LLC200KShares$758,0000.6% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny87.3KShares$330,8670.0% of portfolio
-
Geode Capital Management, LLC Boston, MA87KShares$329,6270.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $41M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...